How Much Weight Can You Actually Lose on GLP-1 Medications?
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) consistently deliver 10–22% total body weight loss in clinical settings. This calculator gives you a realistic estimate based on trial data from the STEP and SURMOUNT programs.
Semaglutide (Ozempic & Wegovy) Weight Loss Expectations
The STEP 1 trial showed an average of 14.9% body weight loss over 68 weeks at the 2.4mg dose. Ozempic at lower doses produces roughly 12–14% on average. See our complete Ozempic guide or use the Drug Comparison Tool.
Tirzepatide (Mounjaro & Zepbound) — Stronger Results
The SURMOUNT-1 trial showed an average 22.5% body weight loss at 15mg. Read our Mounjaro guide or the Semaglutide vs Tirzepatide comparison.
Factors That Influence Your Results
- Dosage escalation: Higher doses generally produce more weight loss.
- Diet quality: See the Protein Calculator.
- Exercise: Resistance training reduces muscle loss. See our Preventing Muscle Loss guide.
- Adherence: Missing doses reduces cumulative efficacy.
Understanding the Weight Loss Plateau
Use the Plateau Calculator to estimate when a plateau might occur and what factors can help break through it.